What is the work you’re leading at KaliVir as CEO? Our goal is to develop viral treatments that can reach and eliminate cancer cells in the body, bringing us closer to a cure for all cancer patients.
Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...
Early research on proton craniospinal irradiation (pCSI) reported potential benefits for patients with LMD. Notably, the final analysis of a randomized phase 2 trial by Yang et al of 63 patients with ...
Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a transformative approach in modern medicine, demonstrating ...